Dc Healthcare Holdings Bhd (XKLS:0283) Research & Development: RM0.00 Mil (TTM As of Mar. 2026)


What is Dc Healthcare Holdings Bhd Research & Development?

Dc Healthcare Holdings Bhd XKLS:0283 Research & Development is RM0.00 Mil as of Mar. 2026. The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Dc Healthcare Holdings Bhd's Research & Development for the three months ended in Mar. 2026 was RM0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.00 Mil.

Dc Healthcare Holdings Bhd  (XKLS:0283) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Dc Healthcare Holdings Bhd Research & Development Related Terms

Dc Healthcare Holdings Bhd Research & Development Historical Data

* Premium members only.

The historical data trend for Dc Healthcare Holdings Bhd's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dc Healthcare Holdings Bhd Research & Development Chart

Dc Healthcare Holdings Bhd Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Dc Healthcare Holdings Bhd Quarterly Data
Dec19 Dec20 Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Dc Healthcare Holdings Bhd Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of RM0.00 Mil mean?
Dc Healthcare Holdings Bhd (XKLS:0283) has a Research & Development of RM0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Dc Healthcare Holdings Bhd and its competitors.
Is Dc Healthcare Holdings Bhd's Research & Development too high?
Dc Healthcare Holdings Bhd's current Research & Development is RM0.00 Mil.
How does Dc Healthcare Holdings Bhd's Research & Development compare to HCA and THC?
Dc Healthcare Holdings Bhd's Research & Development of RM0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Dc Healthcare Holdings Bhd and its competitors. Dc Healthcare Holdings Bhd's current Research & Development is RM0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dc Healthcare Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Dc Healthcare Holdings Bhd (XKLS:0283) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.28, compared to a current price of RM0.10 — trading 64.3% below its estimated fair value. The current Research & Development is RM0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Dc Healthcare Holdings Bhd (XKLS:0283), the current Research & Development is RM0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dc Healthcare Holdings Bhd Business Description

Address Jalan BK5A/2D, A-11-0, A-11-1, A-11-2, Bandar Kinrara, Puchong, SGR, MYS, 47180
Dc Healthcare Holdings Bhd Is an investment holding company. Through its subsidiaries, the company provides Aesthetic Services specializing in Non-Invasive and minimally invasive procedures that includes laser skin rejuvenation, pigmentation and acne treatments, anti-ageing procedures, facial contouring solutions and non-invasive body sculpting. The business activities are categorized into three segments, Aesthetic Services, General Medical Services, and Sale of skincare products. The majority of revenue is derived from the Aesthetic Services segment.